Your session is about to expire
← Back to Search
Neurophysiological Measurement
NeuroCatch™ Platform Assessment for Childhood
N/A
Waitlist Available
Led By Michael Esser
Research Sponsored by Dr. Michael Esser
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion
Eligible Conditions
- Childhood
- Traumatic Brain Injury
- Acute Lymphoblastic Leukemia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Tracking and comparison of neurophysiological changes (ERP response size) to persistence of mTBI symptoms
Tracking and comparison of neurophysiological changes (ERP response timing) to persistence of mTBI symptoms
Secondary outcome measures
Collection of ERP response size (amplitude in microvolts) and response timing (latency in milliseconds)
Number of adverse events and adverse device effects
Other outcome measures
Explore trends between select additional measures of impairment and ERPs across four pediatric cohorts.
Trial Design
1Treatment groups
Experimental Treatment
Group I: NeuroCatch™ Platform AssessmentExperimental Treatment1 Intervention
All participants will undergo two NeuroCatch™ Platform Assessments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NeuroCatch™ Platform
2019
N/A
~140
Find a Location
Who is running the clinical trial?
NeuroCatch Inc.Industry Sponsor
7 Previous Clinical Trials
304 Total Patients Enrolled
Dr. Michael EsserLead Sponsor
Michael EsserPrincipal InvestigatorUniversity of Calgary
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger